Trial Site Detail
Drug: |
Regorafenib + Envafolimab |
|||
|---|---|---|---|---|
Trial: |
A Study of Regorafenib Combined with Envafolimab for Metastatic Gastrointestinal Stromal Tumors with Kit Gene Exon 17 Mutation That Failed Standard Treatment |
|||
| Conditions: | Gastrointestinal Stromal Tumor | |||
Trial Status: |
Recruiting |
|||
Peking University School of Oncology |
Principal Investigator: |
Jian Li |
|---|---|
Contact: |
+861088196088 oncogene@163.com |
Activation Status of this Site: |
Active |
Notes about this Site: |
|
Peking University School of Oncology Website: |
Navigating the Map
Use the plus (+) and minus (-) controls to zoom in/out.
Click and drag the map or use the arrows to move (pan) the map.
Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.